MAR vs MS: Which Is the Better Buy?

Side-by-side comparison of Marriott International, Inc. and Morgan Stanley β€” fair value, conviction, valuation metrics, and QuantHub research signals. Updated 2026-04-22.
Marriott International, Inc. Β· Consumer Cyclical
$377.93
-13.8% upside to fair value
Grade D
VS
Morgan Stanley Β· Financial Services
$189.30
-30.5% upside to fair value
Grade C High Quality
QuantHub Verdict
MAR has more upside to fair value (-13.8%). MS trades at a lower forward P/E (16.4x). These are model outputs β€” not personalized investment advice. See all research β†’
Valuation & Fundamentals
Metric MAR MS
Current Price $377.93 $189.30
Fair Value Estimate $325.87 $131.49
Upside to Fair Value -13.8% -30.5%
Market Cap $100.2B $300.6B
Forward P/E 39.0x 16.4x
EV / EBITDA 25.3x 24.4x
Price / Sales 3.8x 2.5x
Price / FCF 34.6x -16.8x
Revenue Growth YoY +4.1% +18.8%
Gross Margin 21.3% 58.0%
Operating Margin 15.8% 19.5%
Return on Equity -79.9% 16.7%
Dividend Yield 0% 0%
FCF Yield 2.89% β€”
Analyst Consensus Hold Hold
Investment Thesis
MAR β€” Marriott International, Inc.
Marriott International, Inc. operates as the world's largest hospitality company with approximately 9,000 to 9,700 properties across 141 to 143 countries and territories, managing over 30 brands and the largest loyalty program with 203 to 248 million members. The company benefits from a durable competitive moat driven by scale, brand strength, and a growing asset-light credit card royalty busines…
MS β€” Morgan Stanley
Morgan Stanley is a leading global financial services firm operating in Institutional Securities, Wealth Management, and Investment Management. The company benefits from a durable competitive moat supported by its systemically important status, diversified revenue streams, and strong management with a 36-year veteran CEO. Despite solid fundamentals including 14.2% revenue growth in 2025 and 16.7%…
Accumulation Zones
Metric MAR MS
Zone Low $244.40 $98.62
Zone High $276.99 $111.77
In Buy Zone? No No
← MAR Research    MS Research β†’    All Research